Progressive changes in the development toward schizophrenia: Studies in subjects at increased symptomatic risk

Schizophrenia Bulletin

Volumn 34, Issue 2, 2008, Pages 322-329

  Wood, Stephen J ^a,b   Pantelis, Christos ^a   Velakoulis, Dennis ^a   Yücel, Murat ^a   Fornito, Alex ^a   McGorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b National Neuroscience Facility Australia   (Australia)

Author keywords

Neurodevelopment; Neuroimaging; Neuropsychology

Indexed keywords

BRAIN MATURATION; BRAIN REGION; COGNITION; DISEASE COURSE; DISEASE MARKER; ENVIRONMENTAL FACTOR; FRONTAL LOBE; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; LATERAL BRAIN VENTRICLE; NEUROANATOMY; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SYMPTOM;

DISEASE PROGRESSION; FRONTAL LOBE; HUMANS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TEMPORAL LOBE;

EID: 40049097817     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm149     Document Type: Review

References (78)

1. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370.
2. Huber G, Gross G, Schuttler R. Schizophrenie. Verlaufs- und Sozialpsychiatrische Langzeituntersuchungen an den 1945-1959 in Bonn Hospitalisierten Schizophrenen Kranken. Bonn, Germany: Springer; 1979.
3. Phillips LJ, McGorry PD, Yung AR, McGlashan TH, Cornblatt B, Klosterkötter J. Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities. Br J Psychiatry. 2005;48:S33-S44.
4. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand. 2006;113:247-272.
5. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004;67:131-142.
6. Bell RQ. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry. 1992;55:370-381.
7. Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12 month follow-up of a high risk ('prodromal') group. Schizophr Res. 2003;60:21-32.
8. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921-928.
9. McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163:790-799.
10. Morrison AP, French P, Parker S, et al. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull. 2007;33:682-687.
11. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
12. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry. 1998;172:110-120.
13. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry. 1998;55:433-440.
14. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16-25.
15. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry. 2006;188:510-518.
16. Harrison PJ, Lewis DA. Neuropathology of schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. 2nd ed. Oxford, UK: Blackwell Science Ltd.; 2003:310-325.
17. Aleman A, Hijman R, de Haan EHF, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999;156:1358-1366.
18. Copolov D, Velakoulis D, McGorry PD, et al. Neurobiological findings in prodromal and early phase schizophrenia. Brain Res Rev. 2000;31:157-165.
19. Phillips LJ, Velakoulis D, Pantelis C, et al. Non-reduction in hippocampal volume is associated with risk for psychosis. Schizophr Res. 2002;58:145-158.
20. Velakoulis D, Wood SJ, Wong MTH, et al. Hippocampal and amygdala volumes differ according to psychosis stage and diagnosis: an MRI study of chronic schizophrenia, first-episode psychosis and ultra-high risk subjects. Arch Gen Psychiatry. 2006;63:139-149.
21. Stefanis N, Frangou S, Yakeley J, et al. Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol Psychiatry. 1999;46:697-702.
22. Wood SJ, Yücel M, Velakoulis D, et al. Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness. Schizophr Res. 2005;75:295-301.
23. Wood SJ, Berger GE, Velakoulis D, et al. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr Bull. 2003;29:831-844.
24. Jessen F, Scherk H, Träber F, et al. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophr Res. 2006;87:81-88.
25. Eichenbaum H. The hippocampus and mechanisms of declarative memory. Behav Brain Res. 1999;103:123-133.
26. Brewer WJ, Francey SM, Wood SJ, et al. Memory impairments identified in people at ultra high-risk for psychosis who later develop first episode psychosis. Am J Psychiatry. 2005;162:71-78.
27. Borgwardt SJ, Riecher-Rössler A, Dazzan P, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry. 2007;61:1148-1156.
28. Crum WR, Griffin LD, Hill DLG, Hawkes DJ. Zen and the art of medical image registration: correspondence, homology, and quality. Neuroimage. 2003;20:1425-1437.
29. Rosenfeld A, Kak AC. Digital Picture Processing. 2nd ed. Orlando, FL: Academic Press, Inc; 1982.
30. Jones DK, Symms MR, Cercignani M, Howard RJ. The effect of filter size on VBM analyses of DT-MRI data. Neuroimage. 2005;26:546-554.
31. Wood SJ, Pantelis C, Proffitt T, et al. Spatial working memory ability is a marker of risk-for-psychosis. Psychol Med. 2003;33:1239-1247.
32. Niemann D, Becker H, van de Fliert R, et al. Antisaccade performance in patients at ultra high risk for developing psychosis. Schizophr Res. 2007;95:54-60.
33. Brewer WJ, Wood SJ, McGorry PD, et al. Impairment of olfactory identification ability in individuals at ultra high-risk for psychosis who later develop schizophrenia. Am J Psychiatry. 2003;160:1790-1794.
34. Lencz T, Smith CW, McLaughlin DB, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2006;59:863-871.
35. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI study. Lancet. 2003;361:281-288.
36. Morey RA, Inan S, Mitchell TV, Perkins D, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry. 2005;62:254-262.
37. Yücel M, Wood SJ, Fornito A, Riffkin J, Velakoulis D, Pantelis C. Anterior cingulate dysfunction: implications for psychiatric disorders? J Psychiatry Neurosci. 2003;28:350-354.
38. Benes FM. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. Schizophr Bull. 1998;24:219-230.
39. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? [editorial]. BMJ. 1987;295:681-682.
40. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
41. Yücel M, Wood SJ, Phillips LJ, et al. Morphological anomalies of the anterior cingulate cortex in young individuals at ultra high-risk of developing a psychotic illness. Br J Psychiatry. 2003;182:518-524.
42. Yücel M, Stuart GW, Maruff P, et al. Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study. Cereb Cortex. 2001;11:17-25.
43. Yücel M, Stuart GW, Maruff P, et al. Paracingulate morphological differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biol Psychiatry. 2002;52:15-23.
44. Fornito A, Mahli G, Lagopolous J, et al. In vivo evidence for early neurodevelopmental anomaly of the anterior cingulate/paracingulate cortex in bipolar disorder. Acta Psychiatr Scand. In press.
45. Peterson BS, Skudlarski P, Gatenby JC, Zhang H, Anderson AW, Gore JC. An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biol Psychiatry. 1999;45:1237-1258.
46. Keilp JG, Herrera J, Stritzke P, Cornblatt B. The continuous performance test, identical pairs version (CPT-IP): III. Brain functioning during performance of numbers and shapes subtasks. Psychiatr Res. 1997;74:35-45.
47. Francey SM, Jackson HJ, Phillips LJ, Wood SJ, Yung AR, McGorry PD. Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophr Res. 2005;79:127-136.
48. Perlstein W, Carter CS, Barch DM, Baird JW. The Stroop task and attention deficits in schizophrenia: a critical evaluation of card and single-trial Stroop methodologies. Neuropsychology. 1998;12:414-425.
49. 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 1996;58:1929-1935.
50. Fornito A, Wood SJ, Whittle S, et al. Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: associations with cortical thickness, surface area, volume, and sulcal depth. Human Brain Mapp. In press.
51. Fornito A, Yücel M, Whittle S, Wood SJ, Velakoulis D, Pantelis C. The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex. Neuroimage. 2006;33:843-854.
52. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1-52.
53. Berger GE, Wood SJ, Velakoulis D, et al. Ventricle volumes in emerging psychosis. A cross-sectional and longitudinal MRI study. Eur Psychiatry. 2007;22:S30-S31.
54. Aggleton JP. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 1993;16:328-333.
55. Walterfang M, Pantelis C, Velakoulis D, et al. White matter volume changes in people who develop psychosis. Int J Neuropsychopharmacol. 2004;7(suppl 1):S258-S259.
56. Thompson PM, Giedd JN, Woods RP, MacDonald D, Evans AC, Toga AW. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature. 2000;404:190-193.
57. Sun D, Phillips LJ, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Bull. 2007;33:356-357.
58. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA. 2004;101:8174-8179.
59. Wood SJ, Brewer WJ, Koutsouradis P, et al. Cognitive decline following psychosis onset: data from the PACE clinic. Br J Psychiatry. 191;(suppl 51):s52-s57.
60. Phillips LJ, McGorry PD, Garner B, et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry. 2006;40:725-741.
61. Sapolsky RM. Why stress is bad for your brain. Science. 1996;273:749-750.
62. Bremner JD. Does stress damage the brain? Biol Psychiatry. 1999;45:797-805.
63. Yehuda R. Are glucocortoids responsible for putative hippocampal damage in PTSD? How and when to decide. Hippocampus. 2001;11:85-89. discussion 82-84.
64. Cerqueira JJ, Catania C, Sotiropoulos I, et al. Corticosteroid status influences the volume of the rat cingulate cortex - a magnetic resonance imaging study. J Psychiatr Res. 2005;39:451-460.
65. Thompson KN, Phillips LJ, Komesaroff P, et al. Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res. 2007;41:561-569.
66. Garner B, Pariante CM, Wood SJ, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high-risk of developing psychosis. Biol Psychiatry. 2005;58:417-423.
67. Brewer WJ, Wood SJ, Phillips LJ, et al. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull. 2006;32:538-555.
68. Wellard RM, Briellman RS, Jennings C, Jackson GD. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T. Am J Neuroradiol. 2005;26:585-590.
69. Achard S, Salvador R, Whitcher B, Suckling J, Bullmore ET. A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci. 2006;26:63-72.
70. Yücel M, Lubman DI, Harrison BJ, et al. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry. 2007;12:691-702.
71. Yücel M, Harrison BJ, Wood SJ, et al. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry. 2007;64:946-955.
72. Kanaan RA, Kim JS, Kaufmann WE, Pearlson GD, Barker GJ, McGuire PK. Diffusion tensor imaging in schizophrenia. Biol Psychiatry. 2005;58:921-929.
73. Chen Z, Li J, Wei L. A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue. Artif Intell Med. 2007;41:161-175.
74. Pantelis C, Yücel M, Wood SJ, McGorry PD, Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry. 2003;37:399-406.
75. Pantelis C, Yücel M, Wood SJ, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull. 2005;31:672-696.
76. Paus T, Zijdenbos A, Worsley K, et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science. 1999;283:1908-1911.
77. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci. 2005;9:60-68.
78. Wood SJ, Berger GE, Dell'Olio M, et al. Effects of low dose lithium on hippocampal neuropathology in people at ultrahigh risk for psychosis. Biol Psychiatry. 2007;61:259S-260S.